Belair DG, Waller L, Gustin J, Collins N, Kolaja K. Thalidomide inhibits human iPSC mesendoderm differentiation by modulating cereblon-dependent degradation of SALL4. Abstract #3296, Society of Toxicology 58th Annual Meeting, Baltimore, MD, March 2019.